Activity-Based Protein Profiling for Drug Discovery | ABPP Webinar

Added:

Label-Free and Probe-Independent Proteomics

While Activity-Based Protein Profiling (ABPP) is highly effective for mapping active enzyme families, it is fundamentally constrained by its reliance on designed chemical probes. This "probe-dependency" introduces bias, limiting analysis to specific druggable enzyme classes with active-site nucleophiles and leaving non-enzymatic proteins or "undruggable" targets unexamined. Additionally, synthesizing reactive probes can be complex and may generate off-target artifacts. In contrast, probe-independent approaches like Thermal Proteome Profiling (TPP) and Limited Proteolysis-Mass Spectrometry (LiP-MS) offer a powerful alternative. These methods monitor drug-protein interactions across the entire native proteome by measuring changes in protein thermal stability or structural conformation upon ligand binding. By eliminating the need for engineered chemical probes, these label-free techniques provide an unbiased, holistic view of drug target engagement and off-target profiles across all protein classes.

Fundamentals of enzyme kinetics and catalytic mechanisms, particularly how active sites interact with substrates and covalent inhibitors.
Basic organic chemistry principles, including nucleophilic substitution, electrophilic addition, and bioorthogonal conjugation reactions like click chemistry.
Core concepts in proteomics, specifically how mass spectrometry and liquid chromatography are used to identify and quantify proteins in complex biological samples.
An understanding of the traditional drug discovery workflow, focusing on the challenges of target identification and selectivity profiling.
Principles of chemical probe design, including how to optimize reactive 'warheads', reporter tags, and selectivity filters for specific enzyme families.
Competitive ABPP (Activity-Based Protein Profiling) methodologies for high-throughput screening to assess off-target drug interactions and selectivity proteome-wide.
In vivo and in situ chemoproteomics, applying ABPP to study target engagement and drug efficacy directly inside living cells or animal tissues.
Translational clinical applications of ABPP, such as identifying novel disease biomarkers, patient stratification, and monitoring target occupancy in clinical trials.
6.1K views95likes53:22@collaborativedrugdiscovery8352Original Release: 2022-05-06

Activity-based protein profiling (ABPP) is a chemical proteomics technology that uses reactive probes to visualize and characterize enzyme activities in complex proteomes, enabling identification of novel therapeutic targets and accelerating drug discovery by distinguishing active enzymes from inactive ones, thereby overcoming limitations of traditional genomic and proteomic approaches that only measure protein abundance.